This inventor holds 2 USPTO granted patents. Top assignee: Macau University of Science and Technology. Active years: 2018-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018-2022
Title: Innovations of Jia-Ning Mi in Sphingolipid Research
Introduction
Jia-Ning Mi is a prominent inventor based in Taipa, Macau. He has made significant contributions to the field of sphingolipid research, holding a total of 2 patents. His work focuses on methods for isolating and utilizing sphingolipids, which have important implications for treating inflammatory diseases.
Latest Patents
Jia-Ning Mi's latest patents include a method of isolating sphingolipids from cordyceps and their use. This innovative method allows for the extraction of sphingolipid portions that possess exceptional immunosuppressive activities. Additionally, he has developed a method for identifying and quantifying sphingolipids, which involves liquid chromatography and mass spectrometry. These advancements contribute to the understanding and application of sphingolipids in medical treatments.
Career Highlights
Jia-Ning Mi is affiliated with the Macau University of Science and Technology, where he conducts his research. His work has garnered attention for its potential to address autoimmune and allergic diseases through the administration of specific sphingolipids. His contributions to the field are recognized for their innovative approach and practical applications.
Collaborations
Jia-Ning Mi collaborates with notable colleagues such as Jing-Rong Wang and Zhi-Hong Jiang. Their combined expertise enhances the research efforts in sphingolipid studies and contributes to the advancement of medical science.
Conclusion
Jia-Ning Mi's innovative work in sphingolipid research showcases his dedication to advancing medical treatments for inflammatory diseases. His patents and collaborations reflect a commitment to scientific progress and the potential for significant health benefits.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile